The bill enacts a new provision, R.S. 40:978.2.2, which mandates that hospitals conduct fentanyl testing as part of urine drug screenings for minors treated for suspected opioid overdoses. Specifically, if a minor is admitted to a hospital under these circumstances, the hospital is required to include fentanyl testing in the urine drug screening to assist in diagnosing the minor's condition.

Additionally, if fentanyl is detected in the urine drug screening, the hospital must report the de-identified test results to the Louisiana Department of Health, office of public health. The bill also stipulates that hospitals must adhere to any mandatory reporting requirements outlined in the Children's Code Articles 609 and 610, ensuring comprehensive compliance with both the new and existing legal frameworks regarding the treatment and reporting of minors in such cases.